1996
DOI: 10.1007/bf00170839
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the neuropeptide Y Y1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo

Abstract: The possible involvement of neuropeptide Y in sympathetic vasoconstriction in various vascular beds in anesthetized pigs in vivo was studied using the neuropeptide Y Y1 receptor antagonist SR 120107A. Single impulse sympathetic nerve stimulation evoked rapid vasoconstrictor responses in hind limb and nasal mucosa which were not affected by SR 120107A (1.5 mg kg-1). Vascular responses to high frequency stimulation was measured in kidney, spleen (three 1 s bursts at 20 Hz or 300 impulses at 10 Hz), hind limb and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

1998
1998
2008
2008

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 32 publications
1
10
0
Order By: Relevance
“…NPY is known to mediate its pressor effects postsynaptically via Y1-receptors located on arterial vascular smooth muscle cells as has been evidenced in various species and vascular beds [34][35][36][37][38][39][40]. In accordance, in rat mesenteric arteries facilitation of adrenergic vasoconstriction induced by NPY has been demonstrated to be abolished by selective NPY Y1-receptor antagonists [41].…”
Section: Discussionmentioning
confidence: 81%
“…NPY is known to mediate its pressor effects postsynaptically via Y1-receptors located on arterial vascular smooth muscle cells as has been evidenced in various species and vascular beds [34][35][36][37][38][39][40]. In accordance, in rat mesenteric arteries facilitation of adrenergic vasoconstriction induced by NPY has been demonstrated to be abolished by selective NPY Y1-receptor antagonists [41].…”
Section: Discussionmentioning
confidence: 81%
“…Since these alterations occur at doses which antagonize exogenous NPY, and occur without concomitant alterations of blood pressure, these data indicate that endogenous NPY causes tonic renal vasoconstriction in anaesthetized rats. It has also been observed in pigs in vivo that the NPY receptor antagonist SR 120107A inhibits the nerve stimulation-induced vasoconstriction in the kidney but not in several other tissues [66]. Taken together these data indicate that endogenous NPY may be more important in the regulation of vasoconstriction in the kidney than in other vascular beds.…”
Section: Regulation Of Water and Electrolyte Excretion By Npymentioning
confidence: 83%
“…[In parallel, the role of endogenous NPY in sympathetic nerve-evoked postjunctional vascular effects is not clearcut during control conditions (Lundberg and Modin 1995;Malmström and Lundberg 1996), or even after adrenoceptor blockade (unpublished observations).] Alternatively, any effect of NPY may have been still marginal in comparison with α 2 -mediated autoinhibition, taking into account the possibility of an incomplete α 2 -adrenoceptor blockade in combination with an enhanced release of noradrenaline.…”
Section: Discussionmentioning
confidence: 96%
“…-60±4*** -34±2*** +25±3*** -18± 6* BIIE0246 +1±1 -2±2 0±1 +5± 2 + PYY -33±4*** ,✝ -35±6*** +18±2*** -31± 8** Yohimbine -6±5 -6±3 +3±5 +40±13** + BIIE0246 +21±5** ,✝✝ +2±1 -1±1 +5± 2 *P<0.05, **P<0.01, ***P<0.001 significant differences from basal values ✝ P<0.001 significant difference between PYY-evoked response seen in the absence and presence of BIIE0246 ✝✝ P<0.05 significant difference between effect of BIIE0246 in the absence and presence of yohimbine thetic transmitter release in the pig kidney (Lundberg and Modin 1995;Malmström and Lundberg 1996).…”
Section: Pyymentioning
confidence: 93%